Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in hematological patients

This publication has 85 references indexed in Scilit:

• A Controlled Trial of Valganciclovir as Induction Therapy for Cytomegalovirus Retinitis
  New England Journal of Medicine, 2002
• Prophylaxis for CMV should not now replace pre‐emptive therapy in solid organ transplantation
  Reviews in Medical Virology, 2001
• Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation
  New England Journal of Medicine, 1999
• Monitoring of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation
  British Journal of Haematology, 1999
• Expression of Human Herpesvirus-6 Antigens in Benign and Malignant Lymphoproliferative Diseases
  The American Journal of Pathology, 1998
• Primary human herpes virus 6 infection transmitted from donor to recipient through bone marrow infusion
  Bone Marrow Transplantation, 1998
• Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6
  Antiviral Research, 1995
• Human herpesvirus 7: Another causal agent for roseola (exanthem subitum)
  The Journal of Pediatrics, 1994
• Molecular analysis of the immune response to human cytomegalovirus glycoprotein B. I. Mapping of HLA-restricted helper T cell epitopes on gp93
  Journal of General Virology, 1993
• Acyclovir for Prevention of Cytomegalovirus Infection and Disease after Allogeneic Marrow Transplantation
  New England Journal of Medicine, 1988